An Opinion, published in the new Open Access Journal Artificial Intelligence in the Life Sciences from Elsevier, describes the need to extend our current analytical methods to effectively interrogate population data sets. This is required to derive meaningful insights that explain the heterogeneous disease biology and risk for different patient subgroups that underpin precision medicine.
The opinion reflects the challenges that PrecisionLife is solving using our core analytics platform and our focus on high resolution patient stratification as the means to find new treatments for unmet medical need.
Combinatorial analytics: An essential tool for the delivery of precision medicine and precision agriculture,
Artificial Intelligence in the Life Sciences,
The opinion is available online, select the button below.